A novel mouse model of familial combined hyperlipidemia and atherosclerosis.
Chen MJ, Xu YT, Sun L, Wang ZH, Little PJ, Wang L, Xian XD, Weng JP, Xu SW.
Acta Pharmacol Sin. 2024 Jun;45(6):1316-1320. doi: 10.1038/s41401-024-01241-8. Epub 2024 Mar 8.
FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA.
Rev Invest Clin. 2018;70(5):224-236. doi: 10.24875/RIC.18002575.
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.
Trinder M, Vikulova D, Pimstone S, Mancini GBJ, Brunham LR.
Atherosclerosis. 2022 Jan;340:35-43. doi: 10.1016/j.atherosclerosis.2021.11.032. Epub 2021 Dec 6.
Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
Taghizadeh E, Esfehani RJ, Sahebkar A, Parizadeh SM, Rostami D, Mirinezhad M, Poursheikhani A, Mobarhan MG, Pasdar A.
IUBMB Life. 2019 Sep;71(9):1221-1229. doi: 10.1002/iub.2073. Epub 2019 Jul 4.
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
Vikulova DN, Trinder M, Mancini GBJ, Pimstone SN, Brunham LR.
Can J Cardiol. 2021 Nov;37(11):1733-1742. doi: 10.1016/j.cjca.2021.08.012. Epub 2021 Aug 26.
Familial combined hyperlipidemia and insulin resistance : distant relatives linked by intra-abdominal fat?
Eckel RH.
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):469-70. doi: 10.1161/01.atv.21.4.469.
Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review.
Taghizadeh E, Mardani R, Rostami D, Taghizadeh H, Bazireh H, Hayat SMG.
J Cell Biochem. 2019 Jun;120(6):8891-8898. doi: 10.1002/jcb.28311. Epub 2018 Dec 16.
Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC, Lusis AJ, Pajukanta P.
Curr Opin Lipidol. 2006 Apr;17(2):101-9. doi: 10.1097/01.mol.0000217890.54875.13.
Serum complement and familial combined hyperlipidemia.
Ylitalo K, Porkka KV, Meri S, Nuotio I, Suurinkeroinen L, Vakkilainen J, Pajukanta P, Viikari JS, Peltonen L, Ehnholm C, Taskinen MR.
Atherosclerosis. 1997 Mar 21;129(2):271-7. doi: 10.1016/s0021-9150(96)06054-6.
Familial Combined Hyperlipidemia: Myth or Reality?
Brouwers MCGJ, Klop B, Ribalta J, Castro Cabezas M.
Curr Atheroscler Rep. 2025 Apr 1;27(1):45. doi: 10.1007/s11883-025-01289-9.
